Stock information

Explore Novonesis' stock performance, ownership structure, the analysts covering Novonesis and the latest consensus.

Stock ticker - NSIS B

Want to sign up for share alerts?

Stock price

Ownership structure

Novonesis has approximately 100,000 shareholders. Through Novo Holdings, the Novo Nordisk Foundation is the controlling shareholder in Novonesis. Novo Holdings holds 25.50% of the shares and controls 63.35% of the votes.

Novonesis’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share. Novo holdings controls all the A shares.

Analyst coverage

Names and analyst details of the financial institutions covering Novonesis with equity research.

CompanyAnalystEmailPhone no.
AlphaValueJitisha Malhotraj.malhotra@alphavalue.eu-
Bank of AmericaMatthew Yatesmatthew.yates@bofa.com+44 20 7996 4537
BarclaysAlex Sloanealexander.sloane@barclays.com+44 (0) 203 555 0645
BerenbergSebastian Braysebastian.bray@berenberg.com+44 20 3753 3011
Bernstein(Analyst changeover)--
BNP ParibasNicola Tangnicola.tang@uk.bnpparibas.com+44 7785 740855
CitigroupRanulf Orrranulf.orr@citi.com+44 20 7986 3922
Danske BankAndré Thormannthorm@danskebank.dk+45 27 79 29 44
Deutsche BankVirginie Boucher-Fertevirginie.boucher-ferte@db.com+33 144 955934
DNB CarnegieLars Topholmlars.topholm@carnegie.dk+45 32 88 03 53
Goldman SachsGeorgina Frasergeorgina.fraser@gs.com-
Jefferies(Analyst changeover)--
J.P. MorganChetan Udeshichetan.x.udeshi@jpmorgan.com +44 207 742 7034
Jyske BankHaider Anjumhaider.anjum@jyskebank.dk+45 28 30 88 79
Kepler CheuvreuxPatrick Roquasproquas@keplercheuvreux.com+31 20 563 2366
Morgan Stanley(Analyst changeover)--
MorningstarDiana Radudiana.radu@morningstar.com+31 20 797 1557
NordeaThomas Lind Petersenthomas.lind.petersen@nordea.dk+45 55 47 99 38
Rothschild & Co RedburnArtem ChubarovArtem.Chubarov@rothschildandco.com+44 20 7000 2020
SEBSøren Samsøesoren.samsoe@enskilda.dk+45 33 28 33 06
UBS(Analyst changeover)--

Consensus

Download the consensus pre H1 2026.

Contact investor relations

Should you have any questions, please don't hesitate to get in touch with our investor relations team.